| Description |
| Product Type |
Product Size |
| Tablets |
30'S |
| Product Company |
| PMS Pharma |
Exemastane 25mg |
| Product Type |
Product Size |
| Tablet |
10'S |
| Product Company |
| Martin Dow |
Ondansetron 8mg |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Searle Pharma |
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Oncovanz |
Bleomycin 15U |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Getz Pharma |
Trastuzumab 440mg/10ml |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Manufacture Deva Holding / Marketed by Searle |
Letrozole 2.5mg |
| Content | Exemestane is used to treat early breast cancer in women who have experienced menopause ('change of life'; end of monthly menstrual periods). | Ondansetron is one of the medications most commonly used for the empiric treatment of nausea and vomiting. Ondansetron has excellent utility as an antiemetic drug, and it is effective against nausea and vomiting of various etiologies. | Rituximab, an anti CD20 monoclonal antibody, is used in the management of lymphoproliferative and autoimmune conditions. | Bleomycin has approval for adult use in treating squamous cell cancer of head and neck regions, Hodgkin's lymphoma, testicular carcinoma. It is also used as a sclerosing agent for malignant pleural effusions. | Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. | Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon. |
Reviews
There are no reviews yet.